AIA
ABBV icon

Angeles Investment Advisors’s AbbVie ABBV Stock Holding History

Angeles Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,611
Closed -$286K – 32
2024
Q4 		$286K Sell
1,611
-95
-6% -$17.5K 0.01% 146
2024
Q3 		$337K Buy
1,706
+62
+4% +$11.6K 0.02% 153
2024
Q2 		$282K Sell
1,644
-1,415
-46% -$234K 0.01% 168
2024
Q1 		$557K Buy
3,059
+371
+14% +$63.9K 0.03% 101
2023
Q4 		$417K Buy
2,688
+165
+7% +$24.1K 0.03% 121
2023
Q3 		$376K Sell
2,523
-1,052
-29% -$154K 0.03% 114
2023
Q2 		$482K Buy
3,575
+603
+20% +$88.4K 0.04% 69
2023
Q1 		$474K Buy
+2,972
New +$454K 0.04% 61
2022
Q1 		– Sell
-3,188
Closed -$432K – 121
2021
Q4 		$432K Buy
+3,188
New +$377K 0.02% 133

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Angeles Investment Advisors's ABBV Position: Q1 2025 in Review

Angeles Investment Advisors sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,611 shares — an estimated $286K sold.

Angeles Investment Advisors first reported a position in ABBV in Q4 2021 and held it in 9 quarters. The position peaked at $557K in Q1 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Angeles Investment Advisors reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Angeles Investment Advisors sold 1,611 AbbVie shares in Q1 2025, an estimated $286K.
  • Angeles Investment Advisors first reported a position in AbbVie in Q4 2021 and held it in 9 quarters.
  • Angeles Investment Advisors's AbbVie position peaked at $557K in Q1 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.